因美纳伦理咨询委员会

During her 35-year career in medicine, Freda has been on the frontlines of healthcare as a clinician, educator, researcher, and leader in the biopharmaceuticals and life sciences industries. Freda most recently served as Pfizer, Inc.’s Chief Medical Officer and Executive Vice President until the end of 2018 and as Chief Patient Officer and Executive Vice President during 2019. In these roles, Freda expanded outreach to patients, reshaped the focus on patient engagement and inclusion, improved health information and education, and amplified the voice of the patient within company culture and decision-making.

Glenn is a Deputy Dean and Professor of Law at Harvard Law School and the Faculty Director for the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. An award-winning academic and lawyer, Glenn’s work has appeared in leading publications and his amicus briefs have been discussed by the United States Supreme Court. His current research focuses on big data, health information technologies, research ethics, reproductive technology, and health policy.

Les is a clinical and molecular geneticist and is the chief of the Medical Genomics and Metabolic Genetics Branch at the National Human Genome Research Institute (NHGRI) of the National Institutes of Health. Dr. Biesecker directs the ClinSeq project with goals to improve medical care for patients and provide generalized knowledge about genetic disease. He is a member of the National Academy of Medicine.

Nita is the Robinson O. Everett Professor of Law & Philosophy at Duke University, and the Director of Duke Science & Society Initiative. President Obama appointed Nita to the Presidential Commission for the Study of Bioethical Issues in 2010 and she served until 2017. She is a leading scholar on the ethical, legal, and social implications of biosciences and emerging technologies, particularly those related to neuroscience and behavioral genetics.